APM
APM
NASDAQ · Biotechnology

Aptorum Group Ltd-Class A

$0.88
+0.08 (+10.27%)
Analyst Consensus
Strong Buy
6
Analysts
Moderate
Coverage
Buy 5 83%
Hold 1 17%
Sell 0 0%
Price Target
Analyst Price Target +1,311.8% upside
Low Target $9.33
Average Target $12.39
High Target $15.15
Current Price $0.88
Current
$0.88
Target
$12.39
$9.33 $12.39 avg $15.15
Scenario Analysis
Bear Case
$9.33
963.1%
Low target
Base Case
$12.39
+1,311.8%
Avg target
Bull Case
$15.15
+1,626.3%
High target
Risk/Reward
1.7x
Balanced
Price in Context
52-Week High
$4.47
-80.4% from high
52-Week Low
$0.65
+35.0% from low
Target vs 52W High
$12.39
+177.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +19.9%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +157.7%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -2.5%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -69.0%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -12.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -29.5%